ARCHIVES

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

This article is from The Cancer Letter archive.

Vol. 01 No. 48 | November 28, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Test Panels Available For Marker Evaluation

March 2, 1984

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Hybridoma Cell Lines Available from NCI

September 3, 1982

In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores

June 12, 1981

In Brief: AC Committee Picks Seffrin for Executive VP; Charles Wilson Names to NCAB; 5 Leave Board

May 15, 1992

NHGRI Director Francis Collins To Step Down.

May 30, 2008